{
    "clinical_study": {
        "@rank": "148087", 
        "arm_group": [
            {
                "arm_group_label": "Chlorhexidine bathing", 
                "arm_group_type": "Experimental", 
                "description": "Patients in an ICU randomized to treatment arm 1 will be bathed with single use, no rinse, disposable cloths impregnated with 2% chlorhexidine gluconate solution (Sage\u00ae 2% Chlorhexidine Gluconate Cloths).  Bathing of the skin of the arms, chest, abdomen, back, both legs, perineum, and buttocks will be performed daily and as needed after patients become soiled.  The face and neck will not be bathed in this manner but will be bathed with water-moistened washcloths.  All other infection control and cleaning procedures will be performed per the current practice in each intensive care unit."
            }, 
            {
                "arm_group_label": "Non-chlorhexidine bathing", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients in an ICU randomized to treatment arm 2 will be bathed with single use, no rinse, disposable cloths that do not contain chlorhexidine gluconate solution (Sage Comfort Bath\u00ae Cleansing Washcloths).  Bathing of the skin of the arms, chest, abdomen, back, both legs, perineum, and buttocks will be performed daily and as needed after patients become soiled.  The face and neck will not be bathed in this manner but will be bathed with water-moistened washcloths.  All other infection control and cleaning procedures will be performed per the current protocols in each intensive care unit."
            }
        ], 
        "brief_summary": {
            "textblock": "Healthcare-associated infections are a major cause of morbidity among critically ill\n      patients.  Bathing critically ill patients with cloths impregnated with the broad-spectrum\n      antimicrobial agent chlorhexidine-gluconate may decrease healthcare-associated infections.\n      The purpose of this study is to evaluate the effect of daily bathing with disposable\n      chlorhexidine-impregnated bathing cloths, as compared to daily bathing with disposable\n      standard non-chlorhexidine-impregnated bathing cloths, on the rates of healthcare-associated\n      infections in critically-ill patients.\n\n      Hypothesis: Daily bathing of the skin with chlorhexidine-impregnated bathing cloths will\n      result in reduced rates of healthcare-associated infections in patients admitted to\n      intensive care units (ICU)."
        }, 
        "brief_title": "Daily Chlorhexidine Bathing and Infection Rates in Critically-ill Patients", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Healthcare Associated Infections", 
        "condition_browse": {
            "mesh_term": [
                "Critical Illness", 
                "Cross Infection"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All patients admitted to the medical, surgical, trauma, cardiovascular and neuro\n             adult intensive care units at Vanderbilt University Medical Center\n\n        Exclusion Criteria:\n\n          1. Being cared for in the burn ICU or patients with TEN/SJS or burns being cared for in\n             one of the non-burn intensive care units.\n\n          2. Patients with known allergy to chlorhexidine gluconate\n\n          3. Age < 18 years old\n\n          4. Patients where daily bathing would not be safe"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "12000", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02033187", 
            "org_study_id": "120502"
        }, 
        "intervention": [
            {
                "arm_group_label": "Chlorhexidine bathing", 
                "description": "Patients in an ICU randomized to treatment arm 1 will be bathed with single use, no rinse, disposable cloths impregnated with 2% chlorhexidine gluconate solution (Sage\u00ae 2% Chlorhexidine Gluconate Cloths).  Bathing of the skin of the arms, chest, abdomen, back, both legs, perineum, and buttocks will be performed daily and as needed after patients become soiled.  The face and neck will not be bathed in this manner but will be bathed with water-moistened washcloths.  All other infection control and cleaning procedures will be performed per the current practice in each intensive care unit.", 
                "intervention_name": "Chlorhexidine bathing", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Non-chlorhexidine bathing", 
                "description": "Patients in an ICU randomized to treatment arm 2 will be bathed with single use, no rinse, disposable cloths that do not contain chlorhexidine gluconate solution (Sage Comfort Bath\u00ae Cleansing Washcloths).  Bathing of the skin of the arms, chest, abdomen, back, both legs, perineum, and buttocks will be performed daily and as needed after patients become soiled.  The face and neck will not be bathed in this manner but will be bathed with water-moistened washcloths.  All other infection control and cleaning procedures will be performed per the current protocols in each intensive care unit.", 
                "intervention_name": "Non-chlorhexidine bathing", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Chlorhexidine", 
                "Chlorhexidine gluconate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 9, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Nashville", 
                    "country": "United States", 
                    "state": "Tennessee", 
                    "zip": "37232"
                }, 
                "name": "Vanderbilt University Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase 4 Study of the Impact of Daily Bathing With Chlorhexidine-gluconate Impregnated Bathing Cloths on Nosocomial Infections in Critically Ill Patients", 
        "other_outcome": {
            "measure": "Subgroup analysis by the individual intensive care unit", 
            "safety_issue": "No", 
            "time_frame": "One year"
        }, 
        "overall_official": {
            "affiliation": "Vanderbilt University", 
            "last_name": "Michael J Noto, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "A composite of the following healthcare-associated infections:\nCentral line-associated blood stream infections (CLABSI)\nPossible or probable ventilator associated pneumonia (VAP)\nCatheter-associated urinary tract infection (CAUTI)\nC. difficile-associated diarrhea", 
            "measure": "A composite of healthcare-associated infections", 
            "safety_issue": "No", 
            "time_frame": "Daily"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02033187"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Vanderbilt University", 
            "investigator_full_name": "Michael Noto", 
            "investigator_title": "Clinical Fellow, Division of Allergy, Pulmonary, and Critical Care Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Central line-associated blood stream infections (CLABSI)\nPossible or probable ventilator associated pneumonia (VAP)\nCatheter-associated urinary tract infection (CAUTI)\nC. difficile-associated diarrhea", 
                "measure": "Rates of each individual site infection included in the composite calculation above", 
                "safety_issue": "No", 
                "time_frame": "Daily"
            }, 
            {
                "description": "Skin reactions related to topical chlorhexidine", 
                "measure": "Skin reactions", 
                "safety_issue": "Yes", 
                "time_frame": "As needed"
            }, 
            {
                "description": "Hospital mortality", 
                "measure": "Hospital mortality", 
                "safety_issue": "No", 
                "time_frame": "One year"
            }, 
            {
                "description": "Hospital length of stay", 
                "measure": "Hospital length of stay", 
                "safety_issue": "No", 
                "time_frame": "One year"
            }, 
            {
                "description": "ICU length of stay", 
                "measure": "ICU length of stay", 
                "safety_issue": "No", 
                "time_frame": "One year"
            }, 
            {
                "measure": "Rate of cultures positive for multi-drug resistant organisms", 
                "safety_issue": "No", 
                "time_frame": "Daily"
            }, 
            {
                "measure": "Rates of blood culture contamination", 
                "safety_issue": "No", 
                "time_frame": "Daily"
            }, 
            {
                "measure": "Rates of healthcare-acquired bloodstream infections", 
                "safety_issue": "No", 
                "time_frame": "Daily"
            }
        ], 
        "source": "Vanderbilt University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Vanderbilt University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}